Promoting Resilience in Stress Management (PRISM) for women with breast cancer: a qualitative analysis of patient impressions and recommendations [0.03%]
乳腺癌女性压力管理促进韧性的质性分析及患者建议（PRISM）
Molly Ream,Chloe J Taub,Adam Rene Rosenbaum et al.
Molly Ream et al.
Purpose: The Promoting Resilience in Stress Management (PRISM) intervention is a brief, positive psychological skills-based intervention delivered by lay-coaches with demonstrated efficacy at decreasing distress in young ...
Breast cancer patients treated at a New York City academic health system during the COVID-19 pandemic in 2021 had delayed presentations and more advanced disease than pre-pandemic cases [0.03%]
2021年新冠疫情下纽约市学术医疗体系收治的乳腺癌患者病情更晚期
Stephanie Bernik,Tara M Balija,Daniel Kim et al.
Stephanie Bernik et al.
Purpose: The COVID-19 pandemic was associated with a decrease in the incidence of breast cancers in 2020 and was expected to be associated with advanced stage at presentation in the post-pandemic era. The primary objectiv...
The significance of perioperative glucocorticoids in the prevention of seroma formation after mastectomies: a systematic review and meta-analysis [0.03%]
术后皮下积液预防的围术期糖皮质激素应用系统评价和meta分析
Levente Doleviczényi,Lőrinc Frivaldszky,Anett Rancz et al.
Levente Doleviczényi et al.
Purpose: Seroma formation is one of the most common complications after mastectomy. Seromas can lead to repeated aspirations, increase the risk of infection, and potentially delay oncologic treatment. Several strategies h...
Association between hospital volume and survival in patients with locally advanced breast cancer [0.03%]
医疗结构量与局部晚期乳腺癌患者预后之间的关系
Simran Malhotra,Daniel X Choi,Varadan Sevilimedu et al.
Simran Malhotra et al.
Purpose: Prior studies have shown favorable post-surgical outcomes for patients with breast cancer treated at higher-volume hospitals. However, the impact of hospital volume on the management and outcomes for patients wit...
Mesothelin-expressing triple-negative breast cancer: a highly invasive and immunosuppressive subtype [0.03%]
表达间皮素的三阴性乳腺癌：一种侵袭性和免疫抑制性的亚型
Zuxuan Zhao,Huizi Lei,Bingzhi Wang et al.
Zuxuan Zhao et al.
Introduction: Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer with limited therapeutic options. Mesothelin (MSLN), a tumor-associated antigen with potential targeted drugs, has been re...
Analysis of factors associated with loco-regional failure in breast cancer patients following neoadjuvant chemotherapy [0.03%]
新辅助化疗后乳腺癌患者局部区域复发的影响因素分析
Hazim S Ababneh,George E Naoum,Andrzej Niemierko et al.
Hazim S Ababneh et al.
Purpose/objectives: For patients undergoing neoadjuvant chemotherapy (NAC), many clinical factors were identified to be associated with failure. Yet, for patients achieving pathologic complete response (pCR), it remains u...
Cardiovascular adverse events associated with denosumab versus zoledronic acid in patients with breast cancer: a propensity score overlap weighted analysis [0.03%]
降钙素基因相关肽受体刺激的心血管不良事件：.denosumab与唑来膦酸治疗乳腺癌患者的倾向得分类分析
Chikako Iwai,Takaaki Konishi,Atsushi Miyawaki et al.
Chikako Iwai et al.
Background: To compare the risks of cardiovascular events, fractures, and all-cause mortality between denosumab and zoledronic acid in patients with breast cancer bone metastases. ...
Comparative Study
Breast cancer research and treatment. 2025 Nov 25;215(1):16. DOI:10.1007/s10549-025-07852-x 2025
Leah Candell,David Foulad,Irene Wapnir et al.
Leah Candell et al.
Introduction: Limited data is available on patients diagnosed with breast cancer at age 85 and older, and there is no consensus on mammographic screening guidelines for older women, including those with a history of breas...
Worse survival despite indolent features for triple-negative invasive lobular carcinoma: a Swedish nationwide registry-based study [0.03%]
三阴性浸润性小叶癌生存率较低：一项基于瑞典全国登记处的研究
Jenny Nyqvist-Streng,Chaido Chamalidou,Anikó Kovacs et al.
Jenny Nyqvist-Streng et al.
Purpose: To evaluate differences in clinical outcomes, treatments received, recurrence, and sociodemographic characteristics in patients with triple-negative breast cancer (TNBC) classified as invasive lobular carcinoma (...
Collateral damage: rhabdomyolysis from concurrent abemaciclib and rosuvastatin use [0.03%]
并发使用阿贝西利与罗苏伐他汀致横纹肌溶解症
Tae Hoon Kim,Ayah Zobi,Eleonora Teplinsky
Tae Hoon Kim